Moderna, Inc.
name
Moderna, Inc.
id
MRNA
summary
Moderna, Inc. is a pharmaceutical and biotechnology company based in Cambridge, Massachusetts, focusing on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to carry instructions for proteins to produce an immune response. The company's only commercial product is the Moderna COVID-19 vaccine, marketed as Spikevax. Moderna has 45 treatment and vaccine candidates, of which 38 have entered clinical trials, including possible vaccines for influenza, HIV, and cancer vaccines. Founded in 2010, Moderna has raised significant venture capital and became a public company in 2018 via the largest initial public offering of a biotechnology company in history.